6-31952140-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002904.6(NELFE):c.*161A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0999 in 1,507,040 control chromosomes in the GnomAD database, including 8,468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.12 ( 1240 hom., cov: 32)
Exomes 𝑓: 0.098 ( 7228 hom. )
Consequence
NELFE
NM_002904.6 3_prime_UTR
NM_002904.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.114
Publications
40 publications found
Genes affected
NELFE (HGNC:13974): (negative elongation factor complex member E) The protein encoded by this gene is part of a complex termed negative elongation factor (NELF) which represses RNA polymerase II transcript elongation. This protein bears similarity to nuclear RNA-binding proteins; however, it has not been demonstrated that this protein binds RNA. The protein contains a tract of alternating basic and acidic residues, largely arginine (R) and aspartic acid (D). The gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. [provided by RefSeq, Jul 2008]
CFB (HGNC:1037): (complement factor B) This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008]
CFB Gene-Disease associations (from GenCC):
- atypical hemolytic-uremic syndrome with B factor anomalyInheritance: Unknown, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- complement factor b deficiencyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-31952140-T-C is Benign according to our data. Variant chr6-31952140-T-C is described in ClinVar as Benign. ClinVar VariationId is 1227313.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.19 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NELFE | ENST00000375429.8 | c.*161A>G | 3_prime_UTR_variant | Exon 11 of 11 | 1 | NM_002904.6 | ENSP00000364578.3 | |||
| CFB | ENST00000425368.7 | c.*110T>C | downstream_gene_variant | 1 | NM_001710.6 | ENSP00000416561.2 | ||||
| ENSG00000244255 | ENST00000456570.5 | c.*110T>C | downstream_gene_variant | 2 | ENSP00000410815.1 |
Frequencies
GnomAD3 genomes AF: 0.117 AC: 17861AN: 152102Hom.: 1242 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17861
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0980 AC: 132714AN: 1354820Hom.: 7228 Cov.: 21 AF XY: 0.0988 AC XY: 67002AN XY: 677834 show subpopulations
GnomAD4 exome
AF:
AC:
132714
AN:
1354820
Hom.:
Cov.:
21
AF XY:
AC XY:
67002
AN XY:
677834
show subpopulations
African (AFR)
AF:
AC:
5917
AN:
31172
American (AMR)
AF:
AC:
3237
AN:
43550
Ashkenazi Jewish (ASJ)
AF:
AC:
1392
AN:
25000
East Asian (EAS)
AF:
AC:
2890
AN:
39034
South Asian (SAS)
AF:
AC:
12476
AN:
83444
European-Finnish (FIN)
AF:
AC:
3181
AN:
48856
Middle Eastern (MID)
AF:
AC:
364
AN:
5344
European-Non Finnish (NFE)
AF:
AC:
97060
AN:
1021696
Other (OTH)
AF:
AC:
6197
AN:
56724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6561
13122
19683
26244
32805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3650
7300
10950
14600
18250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.117 AC: 17882AN: 152220Hom.: 1240 Cov.: 32 AF XY: 0.115 AC XY: 8583AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
17882
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
8583
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
8016
AN:
41514
American (AMR)
AF:
AC:
1555
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
199
AN:
3470
East Asian (EAS)
AF:
AC:
324
AN:
5188
South Asian (SAS)
AF:
AC:
641
AN:
4812
European-Finnish (FIN)
AF:
AC:
613
AN:
10610
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6189
AN:
68020
Other (OTH)
AF:
AC:
275
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
828
1657
2485
3314
4142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
536
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.